Lung Cancer

1

Monitoring KRAS mutations in circulating DNA and tumor cells using digital droplet PCR during treatment of KRAS-mutated lung adenocarcinoma

Guibert, Nicolas, Pradines, Anne, Farella, Magali, Casanova, Anne, Gouin, Sandrine, Keller, Laura, Favre, Gilles, Mazieres, Julien

Journal:

Lung Cancer

Year:

2016

Language:

english

File:

PDF, 665 KB

english, 2016

2

A phase 2 randomized study of TAS-102 versus topotecan or amrubicin in patients requiring second-line chemotherapy for small cell lung cancer refractory or sensitive to frontline platinum-based chemotherapy

Scagliotti, Giorgio, Nishio, Makoto, Satouchi, Miyako, Valmadre, Giuseppe, Niho, Seiji, Galetta, Domenico, Cortinovis, Diego, Benedetti, Fabio, Yoshihara, Eiji, Makris, Lukas, Inoue, Akira, Kubota, Ka

Journal:

Lung Cancer

Year:

2016

Language:

english

File:

PDF, 391 KB

english, 2016

3

Current patterns of care for patients with extensive stage small cell lung cancer: Survey of US radiation oncologists on their recommendations regarding thoracic consolidation radiotherapy

Mitin, Timur, Jain, Aditya, Degnin, Catherine, Chen, Yiyi, Henderson, Mark, Thomas, Charles R.

Journal:

Lung Cancer

Year:

2016

Language:

english

File:

PDF, 497 KB

english, 2016

4

Randomized phase III PITCAP trial and meta-analysis of induction chemotherapy followed by thoracic irradiation with or without concurrent taxane-based chemotherapy in locally advanced NSCLC

Ardizzoni, Andrea, Tiseo, Marcello, Boni, Luca, Di Maio, Massimo, Buffoni, Lucio, Belvedere, Ornella, Grossi, Francesco, D'Alessandro, Vito, de Marinis, Filippo, Barbera, Santi, Caroti, Cinzia, Favare

Journal:

Lung Cancer

Year:

2016

Language:

english

File:

PDF, 957 KB

english, 2016

5

Is VATS lobectomy standard of care for operable non-small cell lung cancer?

Vannucci, Fernando, Gonzalez-Rivas, Diego

Journal:

Lung Cancer

Year:

2016

Language:

english

File:

PDF, 411 KB

english, 2016

6

Erlotinib has comparable clinical efficacy to chemotherapy in pretreated patients with advanced non-small cell lung cancer (NSCLC): A propensity-adjusted, outcomes research-based study

Neumair, P., Joos, L., Warschkow, R., Dutly, A., Ess, S., Hitz, F., Früh, M., Brutsche, M., Baty, F., Krähenbühl, S., Cerny, T., Joerger, M.

Journal:

Lung Cancer

Year:

2016

Language:

english

File:

PDF, 1.60 MB

english, 2016

7

Somatic alterations in lung cancer: Do environmental factors matter?

Gibelin, Cécilia, Couraud, Sébastien

Journal:

Lung Cancer

Year:

2016

Language:

english

File:

PDF, 841 KB

english, 2016

8

Standardized uptake value on 18F-FDG-PET/CT is a predictor of EGFR T790M mutation status in patients with acquired resistance to EGFR-TKIs

Yoshida, Tatsuya, Tanaka, Hirotaka, Kuroda, Hiroaki, Shimizu, Junichi, Horio, Yoshitsugu, Sakao, Yukinori, Inaba, Yoshitaka, Iwata, Hiroshi, Hida, Toyoaki, Yatabe, Yasushi

Journal:

Lung Cancer

Year:

2016

Language:

english

File:

PDF, 1.12 MB

english, 2016

9

Comparison of survival of chronic obstructive pulmonary disease patients with or without a localized non-small cell lung cancer

Jeppesen, Stefan S., Hansen, Niels-Chr. G., Schytte, Tine, Nielsen, Morten, Hansen, Olfred

Journal:

Lung Cancer

Year:

2016

Language:

english

File:

PDF, 628 KB

english, 2016

10

Increase in soluble PD-1 is associated with prolonged survival in patients with advanced EGFR-mutated non-small cell lung cancer treated with erlotinib

Sorensen, Steffen Filskov, Demuth, Christina, Weber, Britta, Sorensen, Boe Sandahl, Meldgaard, Peter

Journal:

Lung Cancer

Year:

2016

Language:

english

File:

PDF, 751 KB

english, 2016

11

Depression symptom trends and health domains among lung cancer patients in the CanCORS study

Sullivan, D.R., Forsberg, C.W., Ganzini, L., Au, D.H., Gould, M.K., Provenzale, D., Lyons, K.S., Slatore, C.G.

Journal:

Lung Cancer

Year:

2016

Language:

english

File:

PDF, 818 KB

english, 2016

12

The diagnostic value of circulating cell free DNA quantification in non-small cell lung cancer: A systematic review with meta-analysis

Jiang, Tao, Zhai, Changyun, Su, Chunxia, Ren, Shengxiang, Zhou, Caicun

Journal:

Lung Cancer

Year:

2016

Language:

english

File:

PDF, 2.19 MB

english, 2016

13

Scan-associated distress in lung cancer: Quantifying the impact of “scanxiety”

Bauml, Joshua M., Troxel, Andrea, Epperson, C. Neill, Cohen, Roger B., Schmitz, Kathryn, Stricker, Carrie, Shulman, Lawrence N., Bradbury, Angela, Mao, Jun J., Langer, Corey J.

Journal:

Lung Cancer

Year:

2016

Language:

english

File:

PDF, 456 KB

english, 2016

14

Retraction to “Ellipticine-induced apoptosis depends on Akt translocation and signaling in lung epithelial cancer cells”

Fang, Kang, Chen, Shih-Ping, Lin, Chia-Wei, Cheng, Wan-Chun, Huang, Hwei-Tien

Journal:

Lung Cancer

Year:

2016

Language:

english

File:

PDF, 69 KB

english, 2016

15

Immunohistochemical pattern analysis of squamous cell carcinoma: Lung primary and metastatic tumors of head and neck

Ichinose, Junji, Shinozaki-Ushiku, Aya, Nagayama, Kazuhiro, Nitadori, Jun-ichi, Anraku, Masaki, Fukayama, Masashi, Nakajima, Jun, Takai, Daiya

Journal:

Lung Cancer

Year:

2016

Language:

english

File:

PDF, 1.99 MB

english, 2016

16

How does the timing of chemotherapy affect outcome following radical surgery for malignant pleural mesothelioma?

Sharkey, Annabel J., O’Byrne, Kenneth J., Nakas, Apostolos, Tenconi, Sara, Fennell, Dean A., Waller, David A.

Journal:

Lung Cancer

Year:

2016

Language:

english

File:

PDF, 1.07 MB

english, 2016

17

Editorial Board

Journal:

Lung Cancer

Year:

2016

Language:

english

File:

PDF, 68 KB

english, 2016

18

Value of volume-based early metabolic response in patients with unresectable thymic epithelial tumor

Moon, Seung Hwan, Kim, Hae Su, Cho, Young Seok, Sun, Jong-Mu, Ahn, Jin Seok, Park, Keunchil, Kim, Byung-Tae, Ahn, Myung-Ju, Lee, Kyung-Han

Journal:

Lung Cancer

Year:

2016

Language:

english

File:

PDF, 564 KB

english, 2016

Volume 100

Monitoring KRAS mutations in circulating DNA and tumor cells using digital droplet PCR during treatment of KRAS-mutated lung adenocarcinoma

A phase 2 randomized study of TAS-102 versus topotecan or amrubicin in patients requiring second-line chemotherapy for small cell lung cancer refractory or sensitive to frontline platinum-based chemotherapy

Current patterns of care for patients with extensive stage small cell lung cancer: Survey of US radiation oncologists on their recommendations regarding thoracic consolidation radiotherapy

Randomized phase III PITCAP trial and meta-analysis of induction chemotherapy followed by thoracic irradiation with or without concurrent taxane-based chemotherapy in locally advanced NSCLC

Is VATS lobectomy standard of care for operable non-small cell lung cancer?

Erlotinib has comparable clinical efficacy to chemotherapy in pretreated patients with advanced non-small cell lung cancer (NSCLC): A propensity-adjusted, outcomes research-based study

Somatic alterations in lung cancer: Do environmental factors matter?

Standardized uptake value on 18F-FDG-PET/CT is a predictor of EGFR T790M mutation status in patients with acquired resistance to EGFR-TKIs

Comparison of survival of chronic obstructive pulmonary disease patients with or without a localized non-small cell lung cancer

Increase in soluble PD-1 is associated with prolonged survival in patients with advanced EGFR-mutated non-small cell lung cancer treated with erlotinib

Depression symptom trends and health domains among lung cancer patients in the CanCORS study

The diagnostic value of circulating cell free DNA quantification in non-small cell lung cancer: A systematic review with meta-analysis

Scan-associated distress in lung cancer: Quantifying the impact of “scanxiety”

Retraction to “Ellipticine-induced apoptosis depends on Akt translocation and signaling in lung epithelial cancer cells”

Immunohistochemical pattern analysis of squamous cell carcinoma: Lung primary and metastatic tumors of head and neck

How does the timing of chemotherapy affect outcome following radical surgery for malignant pleural mesothelioma?

Editorial Board

Contents

Value of volume-based early metabolic response in patients with unresectable thymic epithelial tumor